ExodusPoint Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,382
| Closed | -$325K | – | 1680 |
|
|
2024
Q1 | $325K | Sell |
6,382
-13,924
| -69% | -$709K | ﹤0.01% | 1124 |
|
|
2023
Q4 | $394K | Buy |
+20,306
| New | +$394K | ﹤0.01% | 1031 |
|
|
2022
Q2 | – | Sell |
-774
| Closed | -$29K | – | 2203 |
|
|
2022
Q1 | $29K | Buy |
+774
| New | +$29K | ﹤0.01% | 2032 |
|
|
2021
Q4 | – | Sell |
-570
| Closed | -$82K | – | 2397 |
|
|
2021
Q3 | $82K | Sell |
570
-323
| -36% | -$46.5K | ﹤0.01% | 1873 |
|
|
2021
Q2 | $165K | Buy |
+893
| New | +$165K | ﹤0.01% | 1963 |
|
|
2020
Q2 | – | Sell |
-4,158
| Closed | -$946K | – | 1900 |
|
|
2020
Q1 | $946K | Sell |
4,158
-2,103
| -34% | -$478K | 0.05% | 283 |
|
|
2019
Q4 | $1.54M | Buy |
+6,261
| New | +$1.54M | 0.03% | 361 |
|